The Elucidator system will be used for protein expression analysis and biomarker discovery.

Eisai licensed Rosetta Biosoftware’s Elucidator® system for differential protein expression analysis and biomarker discovery.

“The Elucidator system will be an important tool for enabling quantitative methods and characterizing cancer proteomes by multidimensional LC-MS/MS,” says Yoshiya Oda, Ph.D., senior scientist at the Laboratory of Seeds Finding Technology. Eisai will use the Elucidator system to help identify potential neurology biomarkers.

According to Rosetta Biosoftware, the Elucidator system supports end-to-end data management and analysis workflow for comparative proteomics. It provides multiple ways to analyze and refine data.

Previous articleHematech Produces Healthy Prion Protein-Knockout Cows
Next articleSartorius Acquires Toha Plast